MRC/UVRI Uganda Research Unit on AIDS, Uganda Virus Research Institute, Entebbe, Uganda.
Trop Med Int Health. 2010 Oct;15(10):1163-71. doi: 10.1111/j.1365-3156.2010.02609.x.
To determine factors associated with pregnant women being HIV positive, barriers to the uptake of single-dose nevirapine (sdNVP) for prevention of mother-to-child transmission (PMTCT) and feasibility and effectiveness of reporting HIV-exposed infants born in facilities with no PMTCT services so as to receive NVP.
From 2002 to 2007, a sdNVP PMTCT service was implemented in 53 rural villages of south-west Uganda. Twenty-five of them were HIV-surveillance study villages. The proportions of mothers testing positive and mother and newborns receiving and ingesting sdNVP and associated factors were determined.
Women with incomplete primary or no education, aged 25-34 years or not living with their partners were at increased risk of being HIV infected. Seventy-seven percentage of pregnant women with HIV (PWH) received therapy. Of the 63 PWH who received therapy and had surviving live births, only 39 (62%) reported births and received newborn prophylaxis within 72 h. Women were more likely to collect and ingest NVP if they were from study villages, preferred home administration of newborn NVP or presented at a more advanced stage of pregnancy. Newborns were more likely to be reported and receive NVP if mothers were aged 25-34 years, on antiretroviral therapy (ART) or came from study villages.
The uptake of PMTCT services was unacceptably low. Asking PWH with less advanced pregnancies to return to collect NVP leads to missed opportunities especially if PWH are less educated. Birth reporting enabled the programme to provide NVP to some infants who otherwise would have missed. Antenatal, delivery and PMTCT services should be integrated.
摘要
确定与 HIV 阳性孕妇相关的因素、单剂量奈韦拉平(sdNVP)用于预防母婴传播(PMTCT)的障碍,以及报告无 PMTCT 服务机构中出生的 HIV 暴露婴儿的可行性和有效性,以便为其提供 NVP。
2002 年至 2007 年,在乌干达西南部的 53 个农村村庄实施了 sdNVP PMTCT 服务。其中 25 个村庄为 HIV 监测研究村庄。确定了母亲检测阳性、母婴接受和服用 sdNVP 的比例以及相关因素。
未完成小学或没有受过教育、年龄在 25-34 岁之间或没有与伴侣生活在一起的妇女感染 HIV 的风险增加。77%的 HIV 阳性孕妇(PWH)接受了治疗。在接受治疗且有存活活产的 63 名 PWH 中,只有 39 名(62%)报告了分娩,并在 72 小时内为新生儿提供了预防措施。如果妇女来自研究村庄、更喜欢在家中为新生儿服用 NVP 或处于妊娠晚期,她们更有可能收集和服用 NVP。如果母亲年龄在 25-34 岁之间、正在接受抗逆转录病毒治疗(ART)或来自研究村庄,新生儿更有可能得到报告并接受 NVP。
PMTCT 服务的利用率低得令人无法接受。要求妊娠晚期较轻的 PWH 回来领取 NVP 会错失机会,尤其是如果 PWH 受教育程度较低。出生报告使该计划能够为一些否则会错过的婴儿提供 NVP。应将产前、分娩和 PMTCT 服务整合。